[ad_1] Pentwater Capital predicted that FTC efforts to block big deals would fail. [ad_2] Source link
Tag: HZNP
Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle
[ad_1] The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact also dismisses the antitrust claims of six states that…
FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
[ad_1] The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. [ad_2] Source link
Drugmakers Raise Prices on Nearly 1,000 Medicines but Show Restraint
[ad_1] Health List prices climb by 5.6% on average as new federal law aims to lower drug costs [ad_2] Source link
Drugmakers Spent Freely in 2022 to Protect Revenue
[ad_1] Pfizer, Amgen and Bristol-Myers Squibb bought makers of proven drugs ahead of potential rising competition from generics. [ad_2] Source link
Amgen Hunts for New Revenue in $28 Billion Deal
[ad_1] Health The purchase of Horizon brings in rare-disease drugs with billions of dollars in sales that could offset revenue drops from patent expiries [ad_2] Source link
First Test for Amgen: Fix Horizon’s Growth Problem
[ad_1] Markets Heard on the Street Sales of Horizon’s thyroid-eye disease drug Tepezza have plateaued, a challenge its new owner will need to contend with [ad_2] Source link
WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon Therapeutics
[ad_1] WSJ News Exclusive Business U.S. biotechnology company was the last of three suitors standing in an auction for Horizon [ad_2] Source link